Carregant...

Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation.

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Biol
Autors principals: Barber, G N, Wambach, M, Thompson, S, Jagus, R, Katze, M G
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 1995
Matèries:
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC230545/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7539103/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.15.6.3138
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!